Weis Holger: insider trades.
Weis Holger reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Weis Holger
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | Officer · CEO | 3 |
| Jupiter Neurosciences, Inc. (JUNS) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Alaunos Therapeutics, Inc. | A | 4,363 | $2.01 | 25,483 | Form 4 |
| 2026-07-23 | Alaunos Therapeutics, Inc. | A | 4,568 | $1.92 | 21,120 | Form 4 |
| 2026-06-30 | Alaunos Therapeutics, Inc. | A | 3,880 | $2.26 | 16,552 | Form 4 |
| 2025-06-02 | Jupiter Neurosciences, Inc. | M | 85,800 | — | 96,581 | Form 4 |
Questions
What stock did Weis Holger buy or sell?
Weis Holger reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.
Is Weis Holger the same person as other filers with this name?
This page covers SEC CIK 1846984 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/weis-holger-1846984.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.